240 related articles for article (PubMed ID: 2158373)
1. Characterisation of stereospecific binding sites for inositol 1,4,5-trisphosphate in airway smooth muscle.
Chilvers ER; Challiss RA; Willcocks AL; Potter BV; Barnes PJ; Nahorski SR
Br J Pharmacol; 1990 Feb; 99(2):297-302. PubMed ID: 2158373
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of [3H]inositol 1,4,5-trisphosphate binding sites in adrenal-cortical membranes. Characterization and validation of a radioreceptor assay.
Challiss RA; Chilvers ER; Willcocks AL; Nahorski SR
Biochem J; 1990 Jan; 265(2):421-7. PubMed ID: 2154189
[TBL] [Abstract][Full Text] [Related]
3. Are there subtypes of the inositol 1,4,5-trisphosphate receptor?
Varney MA; Rivera J; Lopez Bernal A; Watson SP
Biochem J; 1990 Jul; 269(1):211-6. PubMed ID: 2165396
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and application of photoaffinity analogues of inositol 1,4,5-trisphosphate selectively substituted at the 1-phosphate group.
Schäfer R; Nehls-Sahabandu M; Grabowsky B; Dehlinger-Kremer M; Schulz I; Mayr GW
Biochem J; 1990 Dec; 272(3):817-25. PubMed ID: 2176480
[TBL] [Abstract][Full Text] [Related]
5. Characterization of [3H]inositol 1,4,5-trisphosphate binding sites in human temporal cortical and cerebellar membranes.
Garlind A; Cowburn RF; Fowler CJ
Neurochem Int; 1994 Jan; 24(1):73-80. PubMed ID: 8130738
[TBL] [Abstract][Full Text] [Related]
6. Enantiomers of myo-inositol-1,3,4-trisphosphate and myo-inositol-1,4,6 -trisphosphate: stereospecific recognition by cerebellar and platelet myo-inositol-1,4,5-trisphosphate receptors.
Murphy CT; Bullock AJ; Lindley CJ; Mills SJ; Riley AM; Potter BV; Westwick J
Mol Pharmacol; 1996 Nov; 50(5):1223-30. PubMed ID: 8913354
[TBL] [Abstract][Full Text] [Related]
7. Characterization of inositol 1,4,5-trisphosphate- and inositol 1,3,4,5-tetrakisphosphate-binding sites in rat cerebellum.
Challiss RA; Willcocks AL; Mulloy B; Potter BV; Nahorski SR
Biochem J; 1991 Mar; 274 ( Pt 3)(Pt 3):861-7. PubMed ID: 2012613
[TBL] [Abstract][Full Text] [Related]
8. Stereospecific recognition sites for [3H]inositol(1,4,5)-triphosphate in particulate preparations of rat cerebellum.
Willcocks AL; Cooke AM; Potter BV; Nahorski SR
Biochem Biophys Res Commun; 1987 Aug; 146(3):1071-8. PubMed ID: 3039991
[TBL] [Abstract][Full Text] [Related]
9. Characterisation of inositol 1,4,5-trisphosphate binding sites in rabbit aortic smooth muscle.
Murphy TV; Broad LM; Garland CJ
Eur J Pharmacol; 1995 Jul; 290(2):145-50. PubMed ID: 8575529
[TBL] [Abstract][Full Text] [Related]
10. Specific binding of tritium-labeled inositol 1,4,5-trisphosphate to human platelet membranes: ionic and GTP regulation.
Hwang SB
Biochim Biophys Acta; 1991 May; 1064(2):351-9. PubMed ID: 1645202
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of inositol 1,4,5-trisphosphate binding to rat cerebellar and bovine adrenal cortical membranes: evidence for the heterogeneity of binding sites.
Willcocks AL; Challiss RA; Nahorski SR
Eur J Pharmacol; 1990 Sep; 189(2-3):185-93. PubMed ID: 2253702
[TBL] [Abstract][Full Text] [Related]
12. Determination of mass changes in phosphatidylinositol 4,5-bisphosphate and evidence for agonist-stimulated metabolism of inositol 1,4,5-trisphosphate in airway smooth muscle.
Chilvers ER; Batty IH; Challiss RA; Barnes PJ; Nahorski SR
Biochem J; 1991 Apr; 275 ( Pt 2)(Pt 2):373-9. PubMed ID: 1850985
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a novel inositol 1,4,5-trisphosphate receptor in isolated olfactory cilia.
Kalinoski DL; Aldinger SB; Boyle AG; Huque T; Marecek JF; Prestwich GD; Restrepo D
Biochem J; 1992 Jan; 281 ( Pt 2)(Pt 2):449-56. PubMed ID: 1310597
[TBL] [Abstract][Full Text] [Related]
14. Mass changes of inositol(1,4,5)trisphosphate in trachealis muscle following agonist stimulation.
Chilvers ER; Challiss RA; Barnes PJ; Nahorski SR
Eur J Pharmacol; 1989 May; 164(3):587-90. PubMed ID: 2548874
[TBL] [Abstract][Full Text] [Related]
15. Maturation of inositol 1,4,5-trisphosphate receptor binding in rabbit tracheal smooth muscle.
Schramm CM; Chuang ST; Grunstein MM
Am J Physiol; 1992 Oct; 263(4 Pt 1):L501-5. PubMed ID: 1329555
[TBL] [Abstract][Full Text] [Related]
16. Calcium mediates the interconversion between two states of the liver inositol 1,4,5-trisphosphate receptor.
Pietri F; Hilly M; Mauger JP
J Biol Chem; 1990 Oct; 265(29):17478-85. PubMed ID: 2170381
[TBL] [Abstract][Full Text] [Related]
17. Defining the minimal structural requirements for partial agonism at the type I myo-inositol 1,4,5-trisphosphate receptor.
Wilcox RA; Fauq A; Kozikowski AP; Nahorski SR
FEBS Lett; 1997 Feb; 402(2-3):241-5. PubMed ID: 9037203
[TBL] [Abstract][Full Text] [Related]
18. Interaction of synthetic D-6-deoxy-myo-inositol 1,4,5-trisphosphate with the Ca2(+)-releasing D-myo-inositol 1,4,5-trisphosphate receptor, and the metabolic enzymes 5-phosphatase and 3-kinase.
Safrany ST; Wojcikiewicz RJ; Strupish J; Nahorski SR; Dubreuil D; Cleophax J; Gero SD; Potter BV
FEBS Lett; 1991 Jan; 278(2):252-6. PubMed ID: 1846823
[TBL] [Abstract][Full Text] [Related]
19. Molecular target sizes of inositol 1,4,5-trisphosphate receptors in liver and cerebellum.
Nunn DL; Potter BV; Taylor CW
Biochem J; 1990 Jan; 265(2):393-8. PubMed ID: 2154187
[TBL] [Abstract][Full Text] [Related]
20. Influence of Mg2+ and pH on n.m.r. spectra and radioligand binding of inositol 1,4,5-trisphosphate.
White AM; Varney MA; Watson SP; Rigby S; Liu CS; Ward JG; Reese CB; Graham HC; Williams RJ
Biochem J; 1991 Sep; 278 ( Pt 3)(Pt 3):759-64. PubMed ID: 1654891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
